Mammen Mathai
SEC CIK 1421050 · EDGAR
BoughtSold
Most active insiders at TXG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Saxonov Serge | CEO, Dir | — | $6.82M |
| 2 | Taich Adam | CFO | — | $4.84M |
| 3 | STUELPNAGEL JOHN R | Dir | — | $2.39M |
| 4 | Hindson Benjamin J. | See Remarks, Dir | — | $1.46M |
| 5 | SULIMAN SHEHNAAZ | Dir | — | $791.9K |
| 6 | Teichmann Sarah A. | Dir | — | $579.4K |
| 7 | Kosaraju Sridhar | Dir | — | — |
| 8 | MATEO ALAN | Dir | — | — |
| 9 | Popovits Kimberly J | Dir | — | — |
Mammen Mathai made no open-market trades at TXG in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-13 | 2024-06-11 | TXG | 10x Genomics, Inc. | Mammen Mathai | Dir | A - Grant | $0.00 | +8,649 | 180.3K | +5% | $0 | |
| D | 2023-06-16 | 2023-06-14 | TXG | 10x Genomics, Inc. | Mammen Mathai | Dir | A - Grant | $0.00 | +1,865 | 171.6K | +1% | $0 |
| D | 2023-05-15 | 2023-05-11 | TXG | 10x Genomics, Inc. | Mammen Mathai | Dir | M - OptEx | $1.16 | +200.0K | 202.7K | +7,286% | +$232.0K |
| D | 2023-05-15 | 2023-05-11 | TXG | 10x Genomics, Inc. | Mammen Mathai | Dir | S - Sale+OE | $52.82 | -33.0K | 169.7K | -16% | -$1.74M |
| D | 2022-06-17 | 2022-06-15 | TXG | 10x Genomics, Inc. | Mammen Mathai | Dir | A - Grant | $0.00 | +2,120 | 2,745 | +339% | $0 |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Johnson & Johnson | Mammen Mathai | EVP, Pharm, R, D | M - OptEx | $0.00 | +7,740 | 45.3K | +21% | $0 |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Johnson & Johnson | Mammen Mathai | EVP, Pharm, R, D | F - Tax | $165.89 | -3,366 | 41.9K | -7% | -$558.4K |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Johnson & Johnson | Mammen Mathai | EVP, Pharm, R, D | M - OptEx | $0.00 | +7,418 | 39.9K | +23% | $0 |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Johnson & Johnson | Mammen Mathai | EVP, Pharm, R, D | F - Tax | $168.85 | -2,335 | 37.6K | -6% | -$394.3K |
Purchase Sale Sale after option exercise All abbreviations